Therefore, the importance of somatic mutation of CHD1 and germline mutation of CHD4 has been demonstrated in Chinese patients with prostate cancer compared to Western cohorts, highlighting the ethnic characteristics of CHD family genes in Chinese population. This evidence concerns the gene CHD1 and prostate cancer.